However, because C9-ALS and control samples differ by both genotype and disease status, our study cannot determine whether downregulation of C9orf72 expression in specific cell types is directly caused by the repeat expansion mutation, or is also influenced by ALS disease processes. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.